This Company is based on recent discoveries in xenotransplantation, the transplantation of organs from one species to another. By concentrating on abrogating cell-mediated xenograft destruction, XenoCept will offer a promising solution to the worldwide human organ shortage by overcoming the organ rejection problems through genetic engineering to eliminate targets of T cell destruction and provide inhibitors of NK cell lysis